These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3525812)

  • 1. [Application of the sandwich enzyme immunoassay for determination of batroxobin in various animal plasma].
    Sugai K; Imamura Y; Mihashi S; Mori N; Baba S
    Yakugaku Zasshi; 1986 Apr; 106(4):330-4. PubMed ID: 3525812
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels and urinary excretion of batroxobin and its defibrinogenating effects in various animal species.
    Sugai K; Imamura Y; Mihashi S; Ohba M; Kunikane K; Mori N; Baba S
    J Toxicol Sci; 1986 May; 11(2):135-43. PubMed ID: 3522924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of batroxobin levels in the plasma of guinea pigs after epicutaneous and intravenous applications.
    Meier J; Adler C; Weiss N
    Toxicon; 1988; 26(10):964-6. PubMed ID: 3059582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacodynamics and pharmacokinetics of batroxobin in Beagle dog].
    Zheng ZH; Zhu XX; Gan H; Gu RL; Wu ZN; Meng ZY; Dou GF
    Yao Xue Xue Bao; 2013 Aug; 48(8):1307-11. PubMed ID: 24187841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
    Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
    Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Animal experiments on the pharmacokinetics of ocrase (author's transl)].
    Markwardt F; Klöcking HP; Senf L; Schmidt HE; Drawert J; Herzmann H
    Pharmazie; 1979 Dec; 34(12):827-9. PubMed ID: 397495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study of the distribution of terrilytin-125I in the body].
    Andreev SV; Kasatkin IuN; Kubatiev AA; Iurkiv VA; Masenko VP
    Dokl Akad Nauk SSSR; 1975 Jul; 223(3):748-50. PubMed ID: 1192940
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of batroxobin with activated polyethylene glycol: reduction of binding ability towards anti-batroxobin antibody and retention of defibrinogenation activity in circulation of preimmunized dogs.
    Nishimura H; Takahashi K; Sakurai K; Fujinuma K; Imamura Y; Ooba M; Inada Y
    Life Sci; 1983 Oct; 33(15):1467-73. PubMed ID: 6353117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of batroxobin on atherosclerosis].
    Huang J; Zhou D; Tian L; Wu H; Zhang J; Zhang S; Chen H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):197-201. PubMed ID: 12856578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrinogenating effect of batroxobin (Defibrase) in rats and inhibition of migration of human vascular smooth muscle cells by the plasma of batroxobin-treated rats in vitro.
    Wang DS; Hanamoto M; Fang F; Ohba M; Ishii M; Kimura F; Higaki E; Senga H
    Atherosclerosis; 2001 May; 156(1):73-80. PubMed ID: 11368999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of postoperative pericardial adhesions with a defibrinogenating agent.
    Hioki M; Iedokoro Y; Yamagishi S; Yamashita Y; Orii K; Hirano S; Hirata T; Masuda S; Kutukata N; Hisayoshi T; Tanaka S
    Int Surg; 1998; 83(1):11-4. PubMed ID: 9706508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparatice studies on enzyme activity in blood plasma and serum in man, rabbits and rats].
    Methfessel J; Deml L
    Z Klin Chem Klin Biochem; 1967 Nov; 5(6):287-90. PubMed ID: 5596918
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute and repeated dose (28 days) toxicity studies in rats and dogs of recombinant batroxobin, a snake venom thrombin-like enzyme expressed from Pichia pastoris.
    Kim OH; Cho KS; Seomun Y; Kim JT; Chung KH
    Toxicon; 2017 Apr; 129():153-163. PubMed ID: 28161122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activation of proteases in plasmas from various species].
    Lehmann B; Kühne H; Scheuch DW
    Z Med Lab Diagn; 1987; 28(3):127-35. PubMed ID: 3300067
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of arterial thrombolysis with native tissue type plasminogen activator by pretreatment with heparin or batroxobin: an angioscopic study.
    Tomaru T; Uchida Y; Nakamura F; Sonoki H; Tsukamoto M; Sugimoto T
    Am Heart J; 1989 Feb; 117(2):275-81. PubMed ID: 2492737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of natural killer cells in the antimetastatic effect of defibrinogenation with batroxobin].
    Shibuya M; Kawachi S; Aoyama A; Murata A; Baba M; Hirata K; Ohtsuka M; Matsusaka M; Yano T; Niitani H
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2286-92. PubMed ID: 3300562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an enzyme immunoassay for delta sleep-inducing peptide (DSIP) and its use in the determination of the metabolic clearance rate of DSIP administered to dogs.
    Kato N; Honda Y; Ebihara S; Naruse H; Takahashi Y
    Neuroendocrinology; 1984 Jul; 39(1):39-44. PubMed ID: 6379493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GAP-43 expression and pathological changes of temporal infarction in rats and effects of batroxobin.
    Wu W; Guan X; Zhang X; Kuang P
    J Tradit Chin Med; 2002 Mar; 22(1):42-6. PubMed ID: 11977521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal absorption of serrapeptase (TSP) in rats.
    Moriya N; Nakata M; Nakamura M; Takaoka M; Iwasa S; Kato K; Kakinuma A
    Biotechnol Appl Biochem; 1994 Aug; 20(1):101-8. PubMed ID: 7917060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of plasminogen activator by batroxobin.
    Klöcking HP; Hoffmann A; Markwardt F
    Haemostasis; 1987; 17(4):235-7. PubMed ID: 3305231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.